コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 herapeutic antibodies interfere with several laboratory tests.
2 sis of brain echinococcosis was confirmed by laboratory tests.
3 mplement, or even replace, many conventional laboratory tests.
4 ns, biomarkers, and toxins by decentralizing laboratory tests.
5 y compromises the quality and reliability of laboratory tests.
6 g to streptavidin, are used in many clinical laboratory tests.
7 events, vital signs, electrocardiogram, and laboratory tests.
8 herapy or radiation; and 60 (13.6%) were for laboratory tests.
9 size, which is overestimated by low-pressure laboratory tests.
10 e concentration were further investigated in laboratory tests.
11 volumes when compared with standard hospital laboratory tests.
12 electrocardiograms, procedures, and clinical laboratory tests.
13 lts from electrocardiograms, procedures, and laboratory tests.
14 ical examination, psychological testing, and laboratory tests.
15 opsy, gastroscopy, abdominal ultrasound, and laboratory tests.
16 press tests in the field to highly sensitive laboratory tests.
17 the urgent need for noninvasive and reliable laboratory tests.
18 ent, including the review of vital signs and laboratory tests.
19 hods for evaluating persistence are based on laboratory tests.
20 r potential health and climate benefits than laboratory tests.
21 S. purpuratus is affected by temperature in laboratory tests.
22 scrotum was performed together with routine laboratory tests.
23 care had a higher prevalence of recommended laboratory testing.
24 lts; all of them were retested by additional laboratory testing.
25 patients enrolled and the standardization of laboratory testing.
26 ction, primary and secondary prevention, and laboratory testing.
27 ficant reductions in nonstatin therapies and laboratory testing.
28 onary function, echocardiographic image, and laboratory testing.
29 The mainstay of the diagnosis of vWD is laboratory testing.
30 therapy according to the results of routine laboratory testing.
31 characterization and a Bayesian approach to laboratory testing.
32 ction of representative samples and standard laboratory testing.
33 e large majority of cases without overuse of laboratory testing.
34 oving the specificity and feasibility of HIT laboratory testing.
35 d for virus inactivation and subsequent safe laboratory testing.
36 allei, is rapidly detected and identified by laboratory testing.
37 m to improve the reliability and accuracy of laboratory testing.
38 of Ebola virus (EBOV) disease (EVD) requires laboratory testing.
39 tics should be given based on the results of laboratory testing.
40 h electrocardiography, echocardiography, and laboratory testing.
42 erences were $3.45 (95% CI, $1.78-$5.12) for laboratory tests, $124.74 (95% CI, $83.06-$166.42) for a
43 rchers by 13.93% (95% CI, 10.28%-17.43%) for laboratory tests, 13.15% (95% CI, 9.49%-16.66%) for adva
44 higher claims payments than nonsearchers for laboratory tests (4.11%; 95% CI, 1.87%-6.41%), higher pa
45 ompleted a history, physical exam, screening laboratory tests, 7 functional scales, reference serolog
52 er and employee spending for each claim) for laboratory tests, advanced imaging services, and clinici
53 he price transparency platform to search for laboratory tests, advanced imaging services, or clinicia
60 ta from 2015, we evaluated HIV, HCV, and HBV laboratory testing and infection confirmation rates and
61 ogen detection is moderately correlated with laboratory testing and is advantageous in detecting path
62 research with a more integrated approach to laboratory testing and outbreak reporting is essential t
63 educed the proportion of newborns undergoing laboratory testing and receiving empirical antibiotic tr
64 most clinical labs, necessitating reference laboratory testing and thereby delaying the availability
65 because of the atypical presentation, normal laboratory tests and absence of the typical symptoms suc
71 enital Zika virus infection was confirmed by laboratory tests and no controls had confirmed Zika viru
72 s that evaluated imaging tests compared with laboratory tests and other types of tests (17.0 vs 14.0
73 led method validation criteria for automated laboratory tests and proved similar irrespective of the
74 corporate symptoms, signs, and findings from laboratory tests and sometimes endoscopic assessments.
78 s having positive Lyme serology by reference laboratory testing, and there was no difference in distr
79 indings from comprehensive skin examination, laboratory testing, and transvaginal ultrasonography.
82 ource requirements for antiretroviral drugs, laboratory tests, and facility-level personnel and overh
83 es on diagnostic strategies, decision rules, laboratory tests, and imaging studies for the diagnosis
84 dside judgment, interpretation of additional laboratory tests, and initial stabilization, with practi
86 orted for the introduction of new, expensive laboratory tests, and therefore warrant further explorat
87 We observed a low prevalence of recommended laboratory testing, antiviral therapy initiation, and li
90 cause clinical features are non-specific and laboratory tests are insensitive, and treatment delay is
95 holds the promise of complementing existing laboratory tests as a means of assessing hyperandrogenem
97 armacists prescribed medications and ordered laboratory tests as per their scope of practice to achie
103 ntional vehicles (CVs), on average, based on laboratory tests, but there is a paucity of real-world,
104 ties, few evaluations examine disparities in laboratory testing by race/ethnicity, age, sex, Medicaid
105 aditional plasma-based hemostasis-thrombosis laboratory testing, by assessing functional pathways of
106 ewing predictive value relative to timing of laboratory testing can help clinicians develop locally a
109 ological examinations, vital signs, clinical laboratory tests, cerebrospinal fluid laboratory tests,
110 rmance data that will facilitate data-driven laboratory test choices for managing patient care during
111 ng access to the platform, 5.9% of 2,988,663 laboratory test claims, 6.9% of 76,768 advanced imaging
114 ents underwent clinical examination, routine laboratory tests (complete blood count, serum creatinine
115 the new device and assessed it with in-vitro laboratory tests, completed its development to meet regu
116 report questionnaires that we validated with laboratory test confirmation using analysis of hair, uri
120 (i) a reactive CSF Venereal Disease Research Laboratory test (CSF-VDRL), (ii) detection of T. pallidu
121 re compared with those obtained by reference laboratory tests (culture and PCR of blood and cerebrosp
123 differences between emissions from standard laboratory testing cycles and those from actual on-road
124 of long-term failure in relation to routine laboratory test data is presented as a vital step in bri
130 , adjusting for demographic characteristics, laboratory testing, diagnostic imaging, and rotavirus in
131 f the patient care area and the logistics of laboratory testing, diagnostic imaging, and the removal
132 might review safety considerations for these laboratory testing/diagnostic activities that are novel
133 Community Health Index, enabling us to link laboratory tests, dispensed community prescriptions, Sco
134 cookstoves were smaller than predicted from laboratory tests due to the effects of real-world condit
136 ditional assessment (quality of life screen, laboratory testing, echocardiography, and exercise testi
137 rne and wound botulism patients confirmed by laboratory testing, epidemiologic link, or association w
138 f inflammation are often raised, no specific laboratory test exists for the disorder and the diagnosi
139 e operated at the Lawrence Berkeley National Laboratory testing facility with a narrow range of fuel
141 influenza-like illness (ILI) and a positive laboratory test for (H3N2)v, and probable cases had ILI.
142 f symptomatic disease and lack of a specific laboratory test for acute infection complicates diagnosi
144 the availability of a rapid, cost-efficient laboratory test for M. pneumoniae detection that is more
147 hough direct oral anticoagulants do not need laboratory testing for dose adjustment, there are instan
148 disease (EVD) epidemic in West Africa, field laboratory testing for EVD has relied on complex, multi-
151 nce from this study does not support monthly laboratory testing for use of standard doses of oral iso
153 tissue disease, nailfold capillaroscopy and laboratory tests for antinuclear antibodies (ANA) and AN
156 pulation of active persons who had undergone laboratory tests for hemoglobin AS (HbAS) and who were s
158 t the optimal performance and utilization of laboratory tests for the diagnosis of anaplasmosis requi
162 s from a tertiary hospital, including >9.4 M laboratory tests from >530,000 patients, in addition to
164 protocols is highly recommended because the laboratory test guided, protocol-driven transfusion appr
165 n and therefore used vital signs and routine laboratory tests, had the greater case identification wi
169 tocols to establish traceability of clinical laboratory tests, have been established and continue to
170 ention included health education and on-site laboratory testing implemented during baby showers in in
171 he potential clinical utility of this common laboratory test in predicting mortality risk warrants fu
172 population-level data on ART utilization and laboratory testing in British Columbia (1996-2015), we d
173 Current evidence supports limited routine laboratory testing in patients with distal symmetric pol
174 cificity in both point-of-care and reference laboratory testing in this population (maximum cycle thr
175 thy men and women aged 54-76 y who underwent laboratory testing in which we measured cardiovascular,
176 level of clinical suspicion and specialised laboratory testing, in addition to culture, histopatholo
177 ient interviews, medical records review, and laboratory testing including mumps serology and RT-PCR.
178 We collected information regarding various laboratory tests including ESR, CBC with differential, D
179 nsive clinical workup, genetic analysis, and laboratory testing, including measurements of agalA acti
180 set overweight or obesity underwent clinical laboratory testing, including oral glucose tolerance tes
183 ed the absence of fever or jaundice, and the laboratory tests, including that for pancreatic enzymes,
184 ct costs of hospitalization, physician fees, laboratory tests, invasive procedures, outpatient encoun
186 g a clinical diagnosis difficult; therefore, laboratory testing is needed to confirm the diagnosis.
187 result of pyrethroid exposure often seen in laboratory tests is mosquito leg loss, a condition that
188 odel incorporating readily available routine laboratory tests is powerful in identifying breast cance
192 lts of routine diagnostic testing, including laboratory tests, magnetic resonance imaging, and lumbar
194 percholesterolemia based on examinations and laboratory tests, measures of self-reported health statu
195 % threshold of median proportion of positive laboratory tests (median proportion positive (MPP)) to i
197 ic carriage necessitate the use of different laboratory testing methods appropriate for each presenta
198 for BSIs may be delayed because conventional laboratory testing methods take 48 to 72 h to identify a
199 of organic chemicals by linking results from laboratory tests, monitoring and modeling programs.
202 equires awareness in the clinic, appropriate laboratory testing of telomere content, and genetic sequ
207 itivity was obtained by skin tests in 72.9%, laboratory tests only in 2.4% of cases, and oral challen
208 ide accurate diagnosis and avoid unnecessary laboratory testing or incorrect diagnosis of other condi
210 , these sediment samples were incubated with laboratory test organisms, and they exhibited variable t
211 ng (computed tomography or ultrasonography), laboratory tests, parenteral nutrition (PN), peripherall
212 (VWD) is complicated by issues with current laboratory testing, particularly the ristocetin cofactor
213 taken under control with expensive and long laboratory tests performed by direct sampling to evaluat
214 esults from paired glucose meter and central laboratory tests performed within 60 minutes of each oth
219 portal use (communicating by email, viewing laboratory test results and information, and obtaining m
222 ation on diagnoses, dispensation claims, and laboratory test results for all citizens in the Stockhol
223 how that it is possible to 1) determine what laboratory test results physicians consider "normal", 2)
229 (medical history, physical examination, and laboratory test results), and the results of follow-up i
230 e status of 0-2, adequate organ function and laboratory test results, a life expectancy of at least 1
231 a such as clinical symptoms at presentation, laboratory test results, and chest imaging results also
232 record included medications, comorbidities, laboratory test results, and demographics, among others.
233 ical history, physical examinations, fasting laboratory test results, and liver health; all participa
234 ion, and those with extreme abnormalities in laboratory test results, are often identified at present
235 There were no differences between groups in laboratory test results, bone mineral density, or body c
236 sal villous height:crypt depth, serology and laboratory test results, gastrointestinal symptom scores
238 aufen analyses were compared to conventional laboratory test results, that is, BK viremia (quantitati
242 Panels of sera and accompanying clinical and laboratory testing results are now available to Lyme dis
247 Quest Diagnostics offers standardized INR laboratory testing services to approximately half of US
248 clinical test set reading with prior images, laboratory test set reading with prior images, and labor
254 ovide the foundation for developing clinical laboratory testing strategies to guide therapeutic decis
255 picture and can be confirmed with results of laboratory testing, such as serologic tests or polymeras
257 values against those obtained with standard laboratory tests (the Treponema pallidum haemagglutinati
258 By combining behavioural counselling and laboratory testing, the Men's Health Screening Program h
259 th the Guillain-Barre syndrome who underwent laboratory testing, the presence of ZIKV infection was s
261 with influenza-like illness are swabbed for laboratory testing; those testing positive for influenza
262 ng) was the cumulative number of nine common laboratory tests, three radiologic tests, and electrocar
264 nsitivity but remains the most commonly used laboratory test to diagnose pulmonary tuberculosis (TB).
265 y there was scant data on the performance of laboratory testing to detect mecC-mediated beta-lactam r
267 Thus, waiting a short period of time for laboratory tests to characterize leukemias better and de
270 ailable evidence does not support the use of laboratory tests to guide the dose of aspirin or clopido
271 tive to already established standard central laboratory tests to overcome sample transportation and l
274 ya virus (CHIKV) or viral RNA is the primary laboratory test used to diagnose infection in serum coll
275 reening strategies could avoid 25% to 75% of laboratory testing used in CVD risk screening with predi
277 t adult medical literature excluding routine laboratory tests using MEDLINE, EMBASE, and Web of Scien
278 logists can use electronic tools to optimize laboratory test utilization in their health care system.
280 sts have long been advocates for appropriate laboratory test utilization, the widespread availability
281 Uveitis specialists have a high rate of laboratory testing utilization in their evaluation of ne
283 ures included adverse events (AEs), clinical laboratory tests, vital signs, electrocardiograms, and v
284 malaria diagnosis, irrespective of whether a laboratory test was actually done, were 76.8% and 75.9%,
287 individual prevalence of substance use (from laboratory tests) was 7.2% (95% CI 6.1-8.3) in men and 3
288 of diagnosis, clinical characteristics, and laboratory testing were collected from patient charts.
292 cal history, ophthalmologic examination, and laboratory tests were performed at enrollment and every
296 easures of toxicity determined in short-term laboratory tests which are designed to reduce variabilit
297 nificant change in the mean value of several laboratory tests (white blood cell count and hepatic and
298 clinical findings and symptoms together with laboratory tests (white cell count, neutrophil count and
301 07 as a low-cost alternative to conventional laboratory testing, with the goal of improving accessibi
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。